Q2 2024 Holdings
Filed 2024-08-14 | 72 holdings | $1.1B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $103.9M | 1,550,000 | 9.9% |
| Tenet Healthcare Corp(THC) | COM NEW | 88033G407 | $66.5M | 500,000 | 6.3% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $54.2M | 1,000,000 | 5.1% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $50.1M | 650,000 | 4.8% |
| Elevance Health Inc(ELV) | COM | 036752103 | $43.3M | 80,000 | 4.1% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $36.6M | 340,000 | 3.5% |
| Novartis AG(NVSN) | SPONSORED ADR | 66987V109 | $31.9M | 300,000 | 3.0% |
| Longboard Pharmaceuticals in | COM | 54300N103 | $29.7M | 1,100,000 | 2.8% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $29.1M | 235,000 | 2.8% |
| Humana Inc(HUM) | COM | 444859102 | $28.0M | 75,000 | 2.7% |
| Encompass Health Corp(EHC) | COM | 29261A100 | $25.7M | 300,000 | 2.4% |
| Universal Hlth Svcs Inc(UHS) | CL B | 913903100 | $24.0M | 130,000 | 2.3% |
| Ionis Pharmaceuticals Inc(IONS)Call | COM | 462222100 | $23.8M | 500,000 | 2.3% |
| Inari MED Inc(NARIUSD) | COM | 45332Y109 | $19.3M | 400,000 | 1.8% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $18.1M | 500,000 | 1.7% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $17.9M | 400,000 | 1.7% |
| Becton Dickinson & Co(BDX) | COM | 075887109 | $17.5M | 75,000 | 1.7% |
| The Cigna Group(CI) | COM | 125523100 | $16.5M | 50,000 | 1.6% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $16.0M | 590,000 | 1.5% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $15.6M | 85,000 | 1.5% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $15.2M | 275,000 | 1.4% |
| Icon PLC(ICLR) | SHS | G4705A100 | $14.1M | 45,000 | 1.3% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $13.9M | 150,000 | 1.3% |
| Thermo Fisher Scientific Inc(TMO) | COM | 883556102 | $13.8M | 25,000 | 1.3% |
| Quest Diagnostics Inc(DGX) | COM | 74834L100 | $13.7M | 100,000 | 1.3% |
| Viking Therapeutics Inc(VKTX)Call | COM | 92686J106 | $13.3M | 250,000 | 1.3% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $13.3M | 250,000 | 1.3% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $12.6M | 325,000 | 1.2% |
| Amgen Inc(AMGN) | COM | 031162100 | $12.5M | 40,000 | 1.2% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $11.9M | 250,000 | 1.1% |
| Mckesson Corp(MCK) | COM | 58155Q103 | $11.7M | 20,000 | 1.1% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $11.1M | 950,000 | 1.1% |
| Tarsus Pharmaceuticals Inc(TARS)Put | COM | 87650L103 | $10.9M | 400,000 | 1.0% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $9.9M | 145,000 | 0.9% |
| Sanofi(SNY) | SPONSORED ADR | 80105N105 | $9.7M | 200,000 | 0.9% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $9.7M | 220,000 | 0.9% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $9.6M | 70,000 | 0.9% |
| Teleflex Incorporated(TFX) | COM | 879369106 | $9.5M | 45,000 | 0.9% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $9.1M | 10,000 | 0.9% |
| Globus MED Inc(GMED) | CL A | 379577208 | $8.6M | 125,000 | 0.8% |
| Bruker Corp(BRKR) | COM | 116794108 | $8.3M | 130,000 | 0.8% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $8.1M | 150,000 | 0.8% |
| Oscar Health Inc(OSCR) | CL A | 687793109 | $7.9M | 500,000 | 0.8% |
| Repligen Corp(RGEN) | COM | 759916109 | $7.6M | 60,000 | 0.7% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $7.5M | 325,000 | 0.7% |
| Tenaya Therapeutics Inc(TNYA) | COM | 87990A106 | $7.2M | 2,325,000 | 0.7% |
| Sana Biotechnology Inc(SANA) | COM | 799566104 | $6.6M | 1,200,000 | 0.6% |
| Elanco Animal Health Inc(ELAN) | COM | 28414H103 | $6.5M | 450,000 | 0.6% |
| Mereo Biopharma Group PLC(MREO) | SPON ADS | 589492107 | $6.4M | 1,775,000 | 0.6% |
| Merus N V | COM | N5749R100 | $5.9M | 100,000 | 0.6% |